At PDCI Market Access Inc., our vision at PDCI is to be your most trusted and valued pricing and reimbursement strategic partner. To ensure we continue to meet the strategic needs of our customers in the face of the ever-changing Canadian reimbursement landscape, we’ve expanded our Health Economic ... Read More
News & Events
25
Sep2020
10
Sep2020
PDCI Market Access is
pleased to release our premier issue of PDCI
Market Access INSIGHTS online journal to
our Market Access Toolkit subscribers. The articles in our first issue provide
deep dives into:
Planning and budgeting PSPs during the pandemic,New data and new perspectives on private insurers and ... Read More
09
Sep2020
The August 2020 issue of Cell & Gene Therapy Insights, has a focus on Market access: evolving commercialization trends and strategies. PDCI Market Access’ very own Neil Palmer is featured as a guest editor and the author of the article, Under construction: roadmaps for HTA, pricing and ... Read More
09
Sep2020
Palmer-Cell-and-Gene-Theraoy-InsightsDownload
19
Aug2020
PDCI is pleased to announce the release of the 2020 update to the PDCI Census of Insurers. The PDCI Census of Insurers is available exclusively through the PDCI Market Access Toolkit. PDCI’s Census of Insurers estimates the market share and private covered lives by insurer across ... Read More
04
Aug2020
PDCI Launches Sharing Page for Submissions to the PMPRB Draft Guidelines Consultation (Summer 2020)
/ News, What's New
In June 2020, PMPRB launched a public consultation on its new draft Guidelines as a next step towards implementing the recently amended Patented Medicines Regulations. The deadline to submit written feedback is today,August 4, 2020. Details on submitting a consultation response can be found on the PMPRB ... Read More
15
Jul2020
PDCI PMPRB Guidelines Webinar July 22, 2020 between 10:30 am – 12:00 pmIN ADVANCE, PLEASE SUBMIT ANY QUESTIONS YOU WOULD LIKE US TO ADDRESS Please Register here.
13
Jul2020
ALERT! PMPRB WEBINAR RESCHEDULED
Given all the new information this week, as well as the consultation extension, PDCI is postponing its PMPRB webinar. Our second free webinar for industry will now be held on July 22, 2020 between 10:30 am – 12:00 ... Read More
07
Jul2020
PDCI Market Access Inc. is pleased to share its best practices infographic focused on Requesting Reconsideration under the Canadian Agency for Drugs and Technologies in Health (CADTH) Procedures for the Common Drug Review (CDR). While optional and only appropriate in select circumstances, manufacturers should not overlook this potential opportunity ... Read More
02
Jul2020
Request-for-Reconsideration-To-CADTHDownload